Measurements, Thermodynamic Modeling, and a Hydrogen Bonding Study on the Solubilities of Metoprolol Succinate in Organic Solvents [PDF]
The solubilities of metoprolol succinate (a cardioselective β1 adrenergic receptor) in methanol, ethanol, n-propanol, isopropanol, n-butanol, ethyl acetate, and acetone were measured at temperatures ranging from (278.2 to 318.2) K using a solid ...
Xianrui Liang
exaly +5 more sources
Amiodarone vs. metoprolol succinate in HFrEF complicated with persistent atrial fibrillation with rapid ventricular response: A prospective observational study. [PDF]
Backgroundβ-blockers have been recommended for patients with heart failure (HF) and atrial fibrillation (AF), but studies have shown that β-blockers do not reduce all-cause mortality or cardiovascular mortality in patients with HF and AF.ObjectiveTo ...
Liu Y, Hong Y.
europepmc +2 more sources
Development of a Scalable Process of Film-Coated bi-Layer Tablet Containing Sustained-Release Metoprolol Succinate and Immediate-Release Amlodipine Besylate. [PDF]
The development of new drugs that combine active ingredients for the treatment hypertension is critically essential owing to its offering advantages for both patients and manufacturers.
Tuyen NTL, Nghiem LQ, Tuan ND, Le PH.
europepmc +2 more sources
Ten-Year Results of a Single-Center Trial Investigating Heart Rate Control with Ivabradine or Metoprolol Succinate in Patients After Heart Transplantation. [PDF]
Aims: Sinus tachycardia after heart transplantation (HTX) due to cardiac graft denervation is associated with reduced post-transplant survival and requires adequate treatment.
Darche FF +6 more
europepmc +2 more sources
Interaction of palmitic Acid with metoprolol succinate at the binding sites of bovine serum albumin. [PDF]
Purpose: The aim of this study was to characterize the binding profile as well as to notify the interaction of palmitic acid with metoprolol succinate at its binding site on albumin.
Rahman M, Prianka F, Shohel M, Mazid MA.
europepmc +2 more sources
Azelnidipine is a novel dihydropyridine calcium channel antagonist and Metoprolol succinate is a beta blocker, this combination was approved by CDSCO for Phase III clinical trial in April 2021.
Hitanshi Darji, Zarna Dedania
exaly +3 more sources
Effects of low-dose metoprolol succinate sustained-release tablets on patients with paroxysmal atrial fibrillation undergoing circumferential pulmonary vein isolation: a retrospective cohort study. [PDF]
Background The atria, particularly those near the pulmonary vein ostium, have numerous autonomic neural plexuses. Circumferential pulmonary vein isolation (CPVI) can reduce heart rate variability (HRV) parameters.
Ding L, Zhang J, Li B, Jin H.
europepmc +2 more sources
Influencing factors analysis of clinical effect of heart failure patients treated with ivabradine and metoprolol succinate and construction and validation of nomogram prediction model. [PDF]
ObjectiveTo analyze the influencing factors of the clinical effect of ivabradine (Ivab) combined with metoprolol succinate (Met-S) in patients with heart failure (HF), and to construct and verify the nomogram prediction model, in order to provide ...
Wu G +8 more
europepmc +2 more sources
Five-Year Results of Heart Rate Control With Ivabradine or Metoprolol Succinate in Patients After Heart Transplantation [PDF]
Thomas Bruckner +2 more
exaly +2 more sources
The objective of this review was to systematize current data on the -adrenoblockers (-ABs) used in the treatment of cardiovascular diseases and to analyze the results of studies performed with a focus on metoprolol succinate controlled release/extended ...
Marina G. Bubnova
doaj +1 more source

